
AtriCure Inc
NASDAQ:ATRC

Intrinsic Value
The intrinsic value of one
ATRC
stock under the Base Case scenario is
23.05
USD.
Compared to the current market price of 31.76 USD,
AtriCure Inc
is
Overvalued by 27%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
AtriCure Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
AtriCure Inc
Balance Sheet Decomposition
AtriCure Inc
Current Assets | 251.5m |
Cash & Short-Term Investments | 99.9m |
Receivables | 63.3m |
Other Current Assets | 88.3m |
Non-Current Assets | 340.1m |
PP&E | 48.2m |
Intangibles | 289.1m |
Other Non-Current Assets | 2.8m |
Free Cash Flow Analysis
AtriCure Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
AtriCure Inc
Revenue
|
480.1m
USD
|
Cost of Revenue
|
-121.2m
USD
|
Gross Profit
|
358.9m
USD
|
Operating Expenses
|
-393.9m
USD
|
Operating Income
|
-35.1m
USD
|
Other Expenses
|
-3.1m
USD
|
Net Income
|
-38.2m
USD
|
ATRC Profitability Score
Profitability Due Diligence
AtriCure Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Score
AtriCure Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
ATRC Solvency Score
Solvency Due Diligence
AtriCure Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Score
AtriCure Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ATRC Price Targets Summary
AtriCure Inc
According to Wall Street analysts, the average 1-year price target for
ATRC
is 51.38 USD
with a low forecast of 40.4 USD and a high forecast of 63 USD.
Dividends
Current shareholder yield for ATRC is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ATRC
stock under the Base Case scenario is
23.05
USD.
Compared to the current market price of 31.76 USD,
AtriCure Inc
is
Overvalued by 27%.